Literature DB >> 21295570

Phalloidin perturbs the interaction of human non-muscle myosin isoforms 2A and 2C1 with F-actin.

Ralph P Diensthuber1, Mirco Müller, Sarah M Heissler, Manuel H Taft, Igor Chizhov, Dietmar J Manstein.   

Abstract

Phalloidin and fluorescently labeled phalloidin analogs are established reagents to stabilize and mark actin filaments for the investigation of acto-myosin interactions. In the present study, we employed transient and steady-state kinetic measurements as well as in vitro motility assays to show that phalloidin perturbs the productive interaction of human non-muscle myosin-2A and -2C1 with filamentous actin. Phalloidin binding to F-actin results in faster dissociation of the complex formed with non-muscle myosin-2A and -2C1, reduced actin-activated ATP turnover, and slower velocity of actin filaments in the in vitro motility assay. In contrast, phalloidin binding to F-actin does not affect the interaction with human non-muscle myosin isoform 2B and Dictyostelium myosin-2 and myosin-5b.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295570     DOI: 10.1016/j.febslet.2011.01.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3.

Authors:  Manuel H Taft; Elmar Behrmann; Lena-Christin Munske-Weidemann; Claudia Thiel; Stefan Raunser; Dietmar J Manstein
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 2.  Diatrack particle tracking software: Review of applications and performance evaluation.

Authors:  Pascal Vallotton; Antoine M van Oijen; Cynthia B Whitchurch; Vladimir Gelfand; Leslie Yeo; Georgios Tsiavaliaris; Stephanie Heinrich; Elisa Dultz; Karsten Weis; David Grünwald
Journal:  Traffic       Date:  2017-10-23       Impact factor: 6.215

3.  General mechanism of actomyosin contractility.

Authors:  Nilushi L Dasanayake; Paul J Michalski; Anders E Carlsson
Journal:  Phys Rev Lett       Date:  2011-09-08       Impact factor: 9.161

4.  Distinct actin-tropomyosin cofilament populations drive the functional diversification of cytoskeletal myosin motor complexes.

Authors:  Theresia Reindl; Sven Giese; Johannes N Greve; Patrick Y Reinke; Igor Chizhov; Sharissa L Latham; Daniel P Mulvihill; Manuel H Taft; Dietmar J Manstein
Journal:  iScience       Date:  2022-05-30

5.  Myosin-Induced Gliding Patterns at Varied [MgATP] Unveil a Dynamic Actin Filament.

Authors:  Elina Bengtsson; Malin Persson; Mohammad A Rahman; Saroj Kumar; Hideyo Takatsuki; Alf Månsson
Journal:  Biophys J       Date:  2016-10-04       Impact factor: 4.033

Review 6.  Nonmuscle myosin-2: mix and match.

Authors:  Sarah M Heissler; Dietmar J Manstein
Journal:  Cell Mol Life Sci       Date:  2012-05-08       Impact factor: 9.261

7.  Distinct functional interactions between actin isoforms and nonsarcomeric myosins.

Authors:  Mirco Müller; Ralph P Diensthuber; Igor Chizhov; Peter Claus; Sarah M Heissler; Matthias Preller; Manuel H Taft; Dietmar J Manstein
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

8.  Analysis of flexural rigidity of actin filaments propelled by surface adsorbed myosin motors.

Authors:  Elina Bengtsson; Malin Persson; Alf Månsson
Journal:  Cytoskeleton (Hoboken)       Date:  2013-10-04

9.  Bipolar filaments of human nonmuscle myosin 2-A and 2-B have distinct motile and mechanical properties.

Authors:  Luca Melli; Neil Billington; Sara A Sun; Jonathan E Bird; Attila Nagy; Thomas B Friedman; Yasuharu Takagi; James R Sellers
Journal:  Elife       Date:  2018-02-08       Impact factor: 8.140

10.  Three mammalian tropomyosin isoforms have different regulatory effects on nonmuscle myosin-2B and filamentous β-actin in vitro.

Authors:  Salma Pathan-Chhatbar; Manuel H Taft; Theresia Reindl; Nikolas Hundt; Sharissa L Latham; Dietmar J Manstein
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.